A retrospective study to investigate the current situation of biopsy testing in Swedish inoperable Non Small Cell Lung Cancer (NSCLC) patients - MAPSY

Study identifier:NIS-OSE-DUM-2010/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A retrospective, medical record study to investigate the current situation of biopsy testing in the Swedish inoperable Non Small Cell Lung Cancer patient population

Medical condition

Non Small Cell Lung Cancer

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

136

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Oct 2010
Primary Completion Date: 01 Jan 2013
Study Completion Date: 01 Jan 2013

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria